LHG - Litha - Change to the board of Directors

LHG - Litha - Change to the board of Directors                                  
LITHA HEALTHCARE GROUP LIMITED                                                  
(Formerly Myriad Medical Holdings Limited)                                      
Incorporated in the Republic of South Africa                                    
(Registration number 2006/006371/06)                                            
Share code: LHG, ISIN: ZAE000144671                                             
("Litha")                                                                       
CHANGE TO THE BOARD OF DIRECTORS                                                
Shareholders are advised that Fadl Hendricks has been appointed to Litha`s board
of directors as an independent non-executive director, with immediate effect.   
Fadl Hendricks (B.Sc. Chemical Engineering) has specialised in innovative       
chemical engineering technologies. He has worked on several high level projects 
including the development and implementation of new product development and     
portfolio management systems for the commercialisation of newly developed       
businesses in fine chemicals and biotechnology                                  
Fadl has gained extensive experience in process development, technical          
management, project management, plant operational management and business       
development management.                                                         
Fadl has consulted to a number of other companies including the Cape Biotech    
Trust (CBT), one of three Biotechnology Regional Innovation Centres established 
by the Department of Science and Technology (DST). Following this he was        
appointed CEO of CBT in 2006 and held this position until March 2010 until it   
merged with three other biotechnology innovation centres to become the newly    
formed Technology Innovation Agency (TIA). He was appointed as the Group        
Executive of TIA in April 2010 where he has been intensively involved in        
developing business models and processes for this emerging government funded    
innovation agency.                                                              
His specialised expertise will be particularly useful to the board in relation  
to Litha`s Biotechnology division.                                              
23 March 2011                                                                   
Sponsor                                                                         
Java Capital                                                                    
Date: 23/03/2011 14:43:00 Supplied by www.sharenet.co.za                     
Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.